System of pharmacogenomic evaluation for breast cancer treatment with aromatase inhibitors according to a new application designed by ROVI Laboratories
The project's overall objective optimization of management processes and drug delivery
Consortium with Laboratorios Rovi, Biomedadl, Vaxdyn, Hospital Virgen del Rocío, Universidad de Granada, Universidad de Sevilla, Universidad de Cádiz and Genyo.
Program FEDER-INNTERCONECTA for Andalucía
2013-2014
